Effect of cyproterone/acetate (SH-714) on plasma prolactin in patients with prostatic cancer
β Scribed by Holub, G. ;Lunglmayr, G. ;Spona, J.
- Publisher
- Springer
- Year
- 1981
- Tongue
- English
- Weight
- 218 KB
- Volume
- 9
- Category
- Article
- ISSN
- 0300-5623
No coin nor oath required. For personal study only.
β¦ Synopsis
Plasma prolactin was measured in 10 patients with prostatic cancer during treatment with cyproterone acetate (300 mg/week i.m.) Prolactin was assayed during a six month period at weekly intervals during the first 4 weeks and then at monthly intervals. Orchiectomy was not carried out. After 6 months prolactin levels were elevated compared with pre-treatment levels. It is concluded from this study that cyproterone acetate interferes with prolactin secretion by the pituitary gland.
π SIMILAR VOLUMES
## Objectives There have been few reports regarding olanzapine (OLZ)βrelated QT prolongation and hyperprolactinemia. This study evaluated the doseβdependent effect of OLZ on QT interval and plasma prolactin (PRL) level in a single sample of patients with schizophrenia. ## Methods Twentyβsix subje
## Abstract ## BACKGROUND. This pilot randomized controlled trial (RCT) examined the clinical effects of 2 complementary (CAM) therapies, relaxation response therapy (RRT) and Reiki therapy, in men being treated with external beam radiotherapy (EBRx) for prostate cancer. ## METHODS. Study partic
## BACKGROUND. Black race has been associated with a significantly increased risk of prostate cancer mortality. This exploratory analysis investigated the effect of race on the clinical outcome of combined androgen blockade (CAB). METHODS. Data for analysis were obtained from a double-blind, rando